This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Sign in
Sign In or Register
Sign out

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Explore Content

Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

CRESEMBA® in Mucormycosis: Efficacy

In the VITAL trial, CRESEMBA was found to be effective against mucormycosis1. CRESEMBA provides an additional, much-needed treatment option for mucormycosis2-3.

​​​​​​​*Data are n(%)or n/n (%). Overall response was assessed by an independent data review committee and was based on individual clinical, mycological and radiological response assessments. 
​​​​​​​
IQR - interquartile range

Header

This text is for block level content. P tags can go in here too

Dosing

Access dosing information

** This is an optional area where footnotes can live.


References
  1. Marty FM, Ostrosky-Zeichner L, Cornely OA, et al. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016;16(7):828–837.
  2. CRESEMBA GB Summary of Product Characteristics.
  3. Spellberg B, et al. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009;48(12):1743-151. 
PP-CRB-GBR-1208. August 2021

Mucormycosis (Quick Links)

Safety Profile

 CRESEMBA safety information

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

Yes

No

OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.

If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?